Patents by Inventor S. Keith Anderson

S. Keith Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11865150
    Abstract: This document provides methods and materials involved in treating cancer. For example, methods and materials for using an inhibitor of UFM1 activity or expression and/or an inhibitor of UFL1 activity or expression to reduce a cancer cell's ability to carry out a DDR, thereby increasing the sensitivity of cancer cells to treatment with a DNA damaging therapy such as radiation or chemotherapy, are provided.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: January 9, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Evanthia Galanis, S. Keith Anderson, Cheyne B. Kurokawa, Ianko D. Iankov
  • Publication number: 20190365836
    Abstract: This document provides methods and materials involved in treating cancer. For example, methods and materials for using an inhibitor of UFM1 activity or expression and/or an inhibitor of UFL1 activity or expression to reduce a cancer cell's ability to carry out a DDR, thereby increasing the sensitivity of cancer cells to treatment with a DNA damaging therapy such as radiation or chemotherapy, are provided.
    Type: Application
    Filed: January 11, 2018
    Publication date: December 5, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Evanthia GALANIS, S. Keith ANDERSON, Cheyne B. KUROKAWA, Ianko D. IANKOV
  • Patent number: 10407731
    Abstract: This document provides methods and materials related to assessing male mammals (e.g., humans) with prostate cancer. For example, methods and materials for predicting (1) which patients, at the time of PSA reoccurrence, will later develop systemic disease, (2) which patients, at the time of retropubic radial prostatectomy, will later develop systemic disease, and (3) which patients, at the time of systemic disease, will later die from prostate cancer are provided.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: September 10, 2019
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: George G. Klee, Robert B. Jenkins, Thomas M. Kollmeyer, Karla V. Ballman, Eric J. Bergstralh, Bruce W. Morlan, S. Keith Anderson, Tohru Nakagawa
  • Publication number: 20180312926
    Abstract: This document provides methods and materials related to assessing male mammals (e.g., humans) with prostate cancer. For example, methods and materials for predicting (1) which patients, at the time of PSA reoccurrence, will later develop systemic disease, (2) which patients, at the time of retropubic radial prostatectomy, will later develop systemic disease, and (3) which patients, at the time of systemic disease, will later die from prostate cancer are provided.
    Type: Application
    Filed: September 17, 2015
    Publication date: November 1, 2018
    Inventors: George G. Klee, Robert B. Jenkins, Thomas M. Kollmeyer, Karla V. Ballman, Eric J. Bergstralh, Bruce W. Morlan, S. Keith Anderson, Tohru Nakagawa
  • Publication number: 20160010162
    Abstract: This document provides methods and materials related to assessing male mammals (e.g., humans) with prostate cancer. For example, methods and materials for predicting (1) which patients, at the time of PSA reoccurrence, will later develop systemic disease, (2) which patients, at the time of retropubic radial prostatectomy, will later develop systemic disease, and (3) which patients, at the time of systemic disease, will later die from prostate cancer are provided.
    Type: Application
    Filed: September 17, 2015
    Publication date: January 14, 2016
    Inventors: George G. Klee, Robert B. Jenkins, Thomas K. Kollmeyer, Karla V. Ballman, Eric J. Bergstralh, Bruce W. Morlan, S. Keith Anderson, Tohru Nakagawa
  • Publication number: 20090298082
    Abstract: This document provides methods and materials related to assessing male mammals (e.g., humans) with prostate cancer. For example, methods and materials for predicting (1) which patients, at the time of PSA reoccurrence, will later develop systemic disease, (2) which patients, at the time of retropubic radial prostatectomy, will later develop systemic disease, and (3) which patients, at the time of systemic disease, will later die from prostate cancer are provided.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 3, 2009
    Inventors: George G. Klee, Robert B. Jenkins, Thomas M. Kollmeyer, Karla V. Ballman, Eric J. Bergstralh, Bruce W. Morlan, S. Keith Anderson, Tohru Nakagawa